Metabolic & GLP-1 peptides

GLP-1 (glucagon-like peptide-1) is an incretin hormone that stimulates insulin secretion and influences appetite. Engineered analogs dominat…

Semaglutide is a modified GLP-1 receptor agonist peptide designed for extended half-life. It is an approved prescription medicine in many ju…

MOTS-c is a 16-amino-acid mitochondrial-derived peptide studied in metabolic stress and exercise-related experimental models.

Exendin-4 is a 39-residue peptide from Gila monster venom that activates the GLP-1 receptor and inspired the drug exenatide.

Tirzepatide is an engineered dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist peptide. It is an approved p…

Retatrutide is an investigational triple agonist peptide targeting GLP-1, GIP, and glucagon receptors. It is widely discussed in metabolic r…

AOD-9604 is a synthetic peptide related to the C-terminal region of human growth hormone, studied in metabolic and lipolysis-related researc…

Cagrilintide is a long-acting amylin analog peptide investigated for metabolic disease, often discussed alongside GLP-1 and dual/triple agon…

Survodutide (BI 456906) is an investigational dual GLP-1 and glucagon receptor agonist studied in metabolic and liver research. Unlike many …

Mazdutide (IBI362, LY3305677) is a dual GLP-1 and glucagon receptor agonist derived from oxyntomodulin. It has been studied in metabolic res…

Adipotide (Prohibitin-TP01) is an experimental chimeric peptidomimetic that pairs a homing sequence targeting adipose-tissue blood vessels w…